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ABSTRACT 
The gene product of pa1225 found in the opportunistic bacterium Pseudomonas 
aeruginosa strain PAO1 is currently annotated as a putative NAD(P)H dehydrogenase. Prior 
investigation of LysR (PA4203), which regulates the transcription of detoxifying enzymes, 
revealed PA1225 to be the most upregulated gene in the LysR deletion mutant in PAO1. A 
combination of steady-state and rapid kinetics was used to investigate the enzymatic properties of 
PA1225, which may play a potential role in the viability of P. aeruginosa PAO1 in toxic 
environments. In this study, it was experimentally determined that PA1225 catalyzes the oxidation 
of NADPH and NADH to reduce one- and two-ring quinones. PA1225 has a clear preference for 
NADPH as the reducing substrate as determined by a 50-fold difference in kcat/Km with respect to 
NADH at pH 6.0. The effect of pH was also investigated with NADPH and NADH to elucidate 
changes in kred and Kd. 
INDEX WORDS: PA1225, NADH, NADPH, Pseudomonas aeruginosa, reductive-half reaction, 
steady-state, quinone, LysR, detoxifying.    
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1 INTRODUCTION  
The annotation of genes based on computational algorithms, although a valuable tool in the 
arsenal of biologists, inevitably results in inaccurate annotations due to lack of functional and 
biochemical validation. It is estimated that the functional annotation of prokaryotic genes based 
on biochemical evidence represents <0.4% of the microbial genomic genes.1 This is primarily due 
to rapid advancements in the techniques used for genome sequencing, which outperforms the 
biochemical characterization of the gene products. Given the interest in genome sequencing of 
human pathogenic bacteria, the incorrect annotation of genes limits the array of potential targets 
for the development of drugs. 
The Pseudomonas aeruginosa PAO1 complete genetic makeup has been sequenced2, and 
efforts have been carried out to curate the annotations by PseudoCAP, i.e., the Pseudomonas 
Community Annotation Project.3, 4 However, >2,000 genes out of the 5,570 ORFs identified in P. 
aeruginosa PAO1 remained annotated as hypothetical proteins in 2016.3, 5 One of the hypothetical 
proteins, PA1225, is currently annotated as an NAD(P)H dehydrogenase with a flavodoxin-like 
fold, based on ~20-30% sequence identity to human NAD(P)H:quinone reductase 1 (NQO1) and 
NRH:quinone oxidoreductase (NQO2).6, 7 The gene encoding for PA1225 is upregulated 80-fold 
by the deletion of the LysR regulator PA42038, which also upregulates 10- to 16-fold the genes 
encoding for a hypothetical heme oxygenase and a Class I nitronate monooxygenase (NMO)9. No 
direct binding of LysR to the upstream intergenic region of the monocistronic pa1225 gene was 
seen in electrophoretic mobility shift assays, suggesting that overexpression of PA1225 may be 
due to the expression of NMO and a potential involvement of PA1225 in detoxification 
mechanisms.8 
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In this study, the gene product of pa1225 was characterized in vitro to understand its 
catalytic properties that may shed light on its potential involvement during P. aeruginosa PAO1 
detoxification against the mitochondrial toxin propionate-3-nitronate (P3N), the physiological 
substrate of NMO.9 To begin biochemical characterization of PA1225, the pa1225 gene was 
cloned with a C-terminal polyhistidine tag, overexpressed in Escherichia coli Rosetta(DE3)pLysS, 
and purified using a nickel-NTA column. Bioinformatic analysis on PA1225 led to the potential 
reducing and oxidizing substrates that were investigated using steady-state and rapid reaction 
kinetic approaches. The capability of PA1225 to catalyze the oxidation of NADPH or NADH was 
studied using stopped-flow kinetics while altering pH conditions to probe flavin reduction or 
substrate binding changes during the reductive half-reaction. The reductive half-reaction, together 
with steady-state kinetics, established the enzymatic mechanism of PA1225 for the first time. 
 
1.1 Purpose of the Study  
The purpose of this study was to clone, express, and purify PA1225 to carry out 
biochemical characterization using rapid kinetics, apparent steady-state methods, and pH-effects 
on the reductive half-reaction. 
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2 EXPERIMENTAL PROCEDURES 
2.1 Materials 
Genomic DNA of P. aeruginosa PAO1 was a kind gift from Dr. Jim Spain, Georgia 
Institute of Technology, Atlanta, GA. The enzymes NdeI, XhoI, EcoRI, calf intestinal alkaline 
phosphatase, and T4 DNA ligase were from New England Biolabs (Ipswich, MA). 
Phosphodiesterase I was purchased from Worthington (Lakewood, NJ). Pfu DNA polymerase, 
DNase, and RNase were purchased from Agilent (Santa Clara, CA). Oligonucleotides for PCR 
were obtained from Sigma Genosys (The Woodlands, TX). The QIAprep Spin Miniprep Kit and 
the QIAquick PCR Purification Kit were obtained from Qiagen (Valencia, CA). Escherichia coli 
DH5α was purchased from Life Technologies, Inc. E. coli Rosetta(DE3)pLysS and the expression 
vector pET20b(+) were from Novagen (Madison, WI). HiTrapTM chelating HP 5-mL affinity 
column and prepacked PD-10 desalting columns were purchased from GE Healthcare (Piscataway, 
NJ). IPTG was purchased from Promega (Madison, WI). Quinones were purchased from Sigma-
Aldrich (St. Louis, MO). NADH and NADPH disodium salts were purchased from VWR (Radnor, 
PA). All other reagents were of the highest purity commercially available. 
 
2.2 Cloning 
The pa1225 gene was amplified from the genomic DNA of P. aeruginosa PAO1 by PCR 
in the presence of 2 to 6% DMSO and ligated to expression vector pET20b(+). The primers (Table 
1) were designed based on complementary base pair sequence for the pa1225 gene, incorporated 
the sequences encoding for Nde1 and EcoR1 endonuclease sites, and a sequence consisting of six 
bases for proper endonuclease docking. In addition to sequence specification, melting temperature 
(Tm), the possibility of primer dimer formation, and self-annealing sites were also taken into 
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consideration in the initial primer design, by using OligoClac from Northwestern University 
(http://biotools.nubic.northwestern.edu/OligoCalc.html) and Amplify 4 software by Bill Engels 
from the University of Wisconsin (https://engels.genetics.wisc.edu/amplify/). Each PCR reaction 
tube received a calculated cocktail of dNTP, forward and reverse primers, DNA template, and 10x 
cloned Pfu DNA polymerase buffer. The volume of DMSO was calculated and added to each tube 
according to the desired percentage. Lastly, 1 U of Pfu DNA polymerase was added to each PCR 
reaction tube. A Minigene Thermocycler was programmed as follows: (1) initial denaturation at 
95 C for 2 min, (2) 30 s at 95 oC , (3) 1 min at 55 C, (4) 2 min at 70 C , and (5) 5 min at 70 C. 
Steps 2-4 were programmed for 30 cycles. DNA bands, visualized on 1% agarose gel 
electrophoresis, correlated to the expected length of 627 nucleotides, confirming the presence of 
pa1225 DNA. The amplicon and pET20b(+) vector were incubated at 37 oC with 1 U of NdeI and 
EcoRI, in 50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 μg/mL 
BSA, and sterile water in a total reaction volume of 100 μL for 2 h followed by purification using 
QIAprep PCR Purification Kit. After the pET20b(+) plasmid was dephosphorylated with 1 U of 
alkaline phosphatase from calf intestine for 1 h at 37 oC, it was purified using a QIAprep PCR 
purification kit. Then the pET20b(+) vector and pa1225 gene were ligated by incubation at 16 oC 
with 1 U of T4 ligase in 10 mM MgCl2, 50 mM Tris-Cl, 1mM ATP, 10 mM DTT, and a 1:7 
plasmid:pa1225 ratio. The pa1225/pET20b(+) recombinant DNA were transformed into 
chemically competent E. coli strains DH5α and Rosetta(DE3) using heat shock at 42 oC for 30 s. 
Colonies grown at 37 oC on Luria-Bertani agar plates containing 50 µg/mL ampicillin were 
screened for the presence of the desired insert by using Macrogen DNA sequencing services 
(Rockville, MD). The DNA sequences were analyzed using 4Peaks by nucleobytes.com. The DNA 
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sequencing confirmed the correct insertion of the gene in the plasmid vector without undesired 
mutations. 
The recombinant plasmid pa1225/pET20b(+) was used as DNA template for subcloning 
the pa1225 gene to remove EcoRI plus the stop codon,  and incorporate an XhoI restriction site 
plus a C-terminal his-tag. The PCR setup for cloning the gene pa1225 was as follows: (1) an initial 
denaturation step at 95 oC for 5 minutes, (2) denaturation step of 30 s at 95 oC, (3) annealing 
gradient decreasing 0.2 oC every cycle for 1 min at 68 oC, (4) extension for 2 min at 70 oC, and (5) 
a final step for 5 min at 70 oC. Steps 2-4 were programmed for 30 cycles. The amplicon was 
confirmed by the presence of 627 base pair band in 1% agarose electrophoresis gel and purified 
with QIAprep PCR Purification Kit followed by double digestion with NdeI and XhoI. The cut 
amplicon and plasmid were purified once more with a QIAprep PCR Purification Kit. After 
dephosphorylation with 1 U of calf intestine alkaline phosphate for 1 h at 37 oC, the 
dephosphorylated vector was purified with the QIAprep Spin MiniPrep Kit and ligated to the 
pET20b(+) plasmid by incubating for 24 h at 16 oC with T4 DNA ligase. A volume of 5 µL of the 
ligation mixtures was used to transform competent E. coli strain DH5α by heat shock for 30 s at 
42 oC. Colonies grown at 37 oC on Luria-Bertani agar plates containing 50 µg/mL ampicillin were 
screened for the presence of the desired insert with the polyhistidine codons by using Macrogen 
DNA sequencing services (Rockville, MD). The DNA sequences were analyzed using 4Peaks by 
nucleobytes.com. The DNA sequencing confirmed the correct insertion of the gene in the plasmid 
vector without undesired mutations. 
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Table 1 Oligonucleotides used for cloning pa1225. 
Bold: Six-nucleotide tail. Underlined: Restriction site for endonucleases listed top to bottom: NdeI, 
EcoRI, and XhoI.  
 
Forward and Reverse Primers for Non-tagged PA1225 
Forward: 5’AATTGTCATATGCATGCCCTGATCGTCGTCGCTCAT3’ 
Reverse: 5’GATTACGAATTCTCAGGCCTCCAGCGGCTGC3’ 
 
Forward and Reverse Primers for tagged PA1225 
Forward: 5’AATTGTCATATGCATGCCCTGATCGTCGTCGCTCAT3’ 
Reverse: 5’TCTAAACTCGAGGGCCTCCAGCGGCTGCGCC3’ 
 
 
2.3 Overexpression and Purification 
E. coli expression strain Rosetta(DE3)pLysS transformed with pa1225/pET20b(+) was 
used to inoculate 1.5 L of LB broth containing 100 μg/mL ampicillin and 34 µg/mL 
chloramphenicol, and incubated at 37 oC for 18 h with vigorous shaking (200 rpm). When the cell 
culture reached an O.D.600 of 0.6, IPTG was added to a final concentration of 0.2 mM and the 
temperature was lowered to 18 oC for 20 h. The cells were harvested by spinning down at 12,000 
x g for 25 min resulting in 12.4 g of wet cell paste which was resuspended with 50 mL of lysis 
buffer containing 10 mM imidazole, 200 mM NaCl, 10% (v/v) glycerol, 5 mM MgCl2, 1 mM 
PMSF, 2 mg/mL lysozyme, 5 µg/mL DNase, and 5 µg/mL RNase, pH 8.0, on ice. The resuspended 
cells were subjected to 20 min of sonication while on ice. The cell-free extract was obtained after 
centrifugation at 12,500 x g for 25 min and loaded onto a HiTrapTM chelating HP 5 mL affinity 
column equilibrated with Buffer A containing 20 mM sodium phosphate, 200 mM NaCl, 10 mM 
imidazole, 10% glycerol (v/v), pH 8.0. The column was washed with 5 column volumes of 10% 
Buffer B (20 mM sodium phosphate, 200 mM NaCl, 500 mM imidazole, 10% glycerol (v/v), pH 
8.0) at a flow rate of 4 mL/min to remove unwanted protein. PA1225 was eluted with 40% Buffer 
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B (corresponding to 200 mM imidazole), and the purest fractions based on SDS-PAGE analysis 
were pooled, dialyzed against 20 mM Tris-Cl, 150 mM NaCl, 10% glycerol (v/v), and stored at -
20oC. The specific activity (U/mg) determined during purification of PA1225 was determined in 
20 mM Tris-Cl, 150 mM NaCl, pH 8.0, at 25 oC, by measuring the consumption of NADPH at 340 
nm at a fixed concentration of NADPH and 1,4-benzoquinone, both at 0.2 mM. One unit of enzyme 
activity is defined as the amount of enzyme that catalyzes the oxidation of 1 μmole of NADPH per 
minute at 25oC in 20 mM Tris-Cl, 150 mM NaCl, at pH 8.0.  
 
2.4 Cofactor Identification 
Fluorescence emission spectra were recorded in 0.11 M Tris-Cl, 0.11 M NaCl, and 15 
MgCl2 at pH 8.9 using a Shimadzu model RF-5301 PC spectrofluorometer (Kyoto, Japan) with a 
1 cm path length quartz at 25 oC. The release of PA1225 cofactor was achieved by heating at 100 
oC for 15 minutes followed by centrifugation at 20,000 x g for 20 min to remove the denatured 
protein. The released cofactor was passed through a prepacked, disposable PD10 column for buffer 
exchange with 0.11 M Tris-Cl, 0.11 M NaCl, and 15 mM MgCl2 at pH 8.9, which are the conditions 
in which phosphodiesterase I works optimally. The concentration of free flavin was quantitatively 
calculated by measuring the absorbance at 450 nm and the solution brought to a final volume of 3 
mL. PA1225 at 2 μM was excited at 460 nm (444 nm for free flavin), and the emission scan was 
determined from 460 nm to 650 nm. After one unit of phosphodiesterase I was added to the 
cofactor sample, the fluorescence emission and excitation were recorded for 40 min until no 
change in peak intensity was observed. A positive control using 2 M of commercial FAD was 
used to ensure phosphodiesterase I was active. 
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Cofactor identification was also performed by mass spectrometry of the extracted flavin at 
5 μM in α-cyano-4-hydroxycinnamic acid matrix at the Georgia State University Chemistry Core 
Facility equipped with Bruker Daltonics ultrafleXtreme MALDI-TOF in negative ion mode. The 
cofactor was extracted by heat denaturation at 100 oC for 20 min followed by centrifugation and 
desalted by passing through a PD10 column equilibrated with water. A commercially available 
free FAD at 10 μM dissolved in H2O was submitted as a positive control.   
 
2.5 Spectroscopic Properties 
The UV-visible absorbance of PA1225, extracted flavin, and commercial FAD, were 
recorded with an Agilent Technologies diode-array spectrophotometer model HP 8453 PC (Santa 
Clara, CA) equipped with a thermostated water bath in 20 mM Tris-Cl, 150 mM NaCl, 10% 
glycerol, pH 8.0, at 25 oC. The extinction coefficient of the enzyme-bound flavin was determined 
by heating PA1225 at 100 oC for 20 min, followed by centrifugation at 20,000 x g for 20 min to 
remove the denatured protein, and recording of the UV-visible absorption spectrum of the 
extracted flavin. The concentration of the extracted FAD was determined spectroscopically by 
using the extinction coefficient of free FAD Ԑ450 = 11,300 M-1 cm-1.10 The extinction coefficient 
of enzyme-bound flavin was experimentally calculated by taking the ratio of A450/ Ԑ450 value for 
the extracted FAD and multiplying by the A460 value of the enzyme-bound flavin, yielding Ԑ460 = 
10,100 M-1 cm-1. The concentration of NAD(P)H was determined spectroscopically by using the 
molar absorptivity of Ԑ340 = 6,220 M-1 cm-1.11 The total protein concentration was quantitated using 
Bradford assay with bovine serum album as a standard.12 
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2.6 Enzymatic Activity  
The enzymatic activity of PA1225 with NADH or NADPH was monitored aerobically with 
a fixed, saturating concentration of 0.2 mM benzoquinone in 20 mM sodium phosphate, 150 mM 
NaCl, 10% glycerol, pH 6.0, using a diode-array spectrophotometer equipped with a thermostated 
water bath at 25 oC. PA1225 was prepared by passing through a PD 10 column equilibrated in 
buffer prior to kinetic analysis. A stock solution of benzoquinone was prepared in 200 proof 
ethanol at a concentration of 25 mM. Working concentrations of 0.2 mM benzoquinone and 0.4 
μM PA1225 were prepared by dissolving calculated aliquots of stock benzoquinone solution in the 
enzymatic buffer with PA1225. An NAD(P)H stock concentration of 15 mM was determined 
spectroscopically, and subsequent NAD(P)H working concentrations were prepared such that 25 
μL of NAD(P)H was needed to achieve the desired final concentration for all points in a 1 mL 
reaction mixture. 
In the case of steady-state with quinones at a fixed concentration of 0.2 mM NADPH or 
NADH, the enzymatic activity of PA1225 was monitored aerobically with benzoquinone, 
tetramethyl-1,4-benzoquinone, 2,6-dimethoxy-1,4-benzoquinone, Coenzyme Qo, or 1,4-
naphthoquinone, in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, using a diode-array 
spectrophotometer equipped with a thermostated water bath at 25 oC. PA1225 was prepared by 
passing through a PD 10 column equilibrated with 20 mM sodium phosphate, 150 mM NaCl, pH 
6.0 prior to kinetic analysis. Quinone solutions were prepared in 200 proof ethanol except for 2,6-
dimethoxy-1,4-benzoquinone, which was dissolved in DMSO at a stock concentration of 25 mM. 
Data acquisition was initiated by addition of NAD(P)H in the reaction mixture and the initial rates 
were measured by following the oxidation of NAD(P)H at 340 nm. The rates were normalized by 
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the control reaction in the absence of enzyme for all experiments and to the concentration of 
enzyme-bound flavin. The experiments were done in triplicate.  
The oxidase activity of PA1225 at 0.4 μM was tested in the presence of atmospheric oxygen 
with a concentration of 253 µM and saturating 0.2 mM NADPH in 20 mM sodium phosphate, 150 
mM NaCl, pH 6.0, using a diode-array spectrophotometer equipped with a water bath at 25 oC. In 
a 1 mL, 1 cm quartz cuvette, the non-enzymatic reaction with 0.2 mM NADPH and atmospheric 
was monitored for 60 s at 25 oC. The enzymatic reaction with 0.4 µM PA1225, 0.2 mM NADPH, 
and atmospheric oxygen at 25 oC was normalized for the non-enzymatic reaction and to the 
concentration of enzyme-bound flavin. The measurements for initial rate were performed in 
duplicate. 
The azoreductase activity of PA1225 was monitored by the reduction of methyl red at 
430 nm using Ԑ430 of 23,360 M-1 cm-1,13 in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, 
using a diode-array spectrophotometer equipped with a thermostated water bath at 25 oC. The 
final concentrations of NADPH, benzoquinone, and PA1225, in a 1 mL quartz cuvette were 0.2 
mM for both substrates and 0.4 μM for the enzyme. The reaction was initiated with the addition 
of either 0.1 mM or 0.2 mM methyl red. The non-enzymatic rate, in the absence of PA1225, was 
equivalent to the observed rate in the presence of catalyst. The measurements were done in 
triplicate. 
 
2.7 Reductive Half-Reaction 
All stopped-flow studies were performed at 25 oC using a Hi-Tech Scientific SF-61 DX2 
stopped-flow spectrophotometer, equipped with a photo-diode array and mountable 
photomultiplier detector, under aerobic conditions. Stopped-flow syringes were cleaned 
11 
thoroughly, and the baseline recorded with the desired buffer. At a concentration of 25 μM, 
PA1225 was gel filtered through a PD 10 column against 20 mM sodium phosphate, 150 mM 
NaCl, 10% glycerol (for pH 6.0) or 20 mM Tris-Cl, 150 mM NaCl, 10% glycerol (for pH 8.0 and 
9.0) or 20 mM sodium pyrophosphate, 150 mM NaCl, 10% glycerol (for pH 10.0). The final 
concentration of PA1225 at all pH values was approximately 10 µM, as determined by a single 
scan of the enzyme after rapid mixing with an equal volume of buffer in the stopped-flow 
spectrophotometer. An NAD(P)H stock solution was prepared fresh on the same day in the desired 
buffer. Subsequent NAD(P)H working concentrations were prepared by dilution to a final volume 
of 2 mL. For the reductive half-reaction with NADH or NADPH at pH 6.0, an NADH 
concentration range of 0.5 mM to 8 mM was used, and an NADPH range of 0.5 mM to 1.0 mM 
was used. For pH 8.0, an NADH range of 1.0 mM to 10.0 mM was used, and an NADPH range of 
0.2 mM to 6.0 mM was used. For pH 9.0, an NADH range of 2.0 mM to 15.0 mM was used, and 
an NADPH range of 0.1 mM to 1.0 mM was used. For pH 10.0, an NADH range of 2.0 mM to 
15.0 mM was used, and an NADPH range of 0.5 mM to 8.0 mM was used. In all cases, the range 
of substrate concentrations was chosen to ensure proper determination of the Kd value.  Each 
measurement was carried out in triplicate for NADH and NADPH at all pH values tested.  
 
2.8 Steady-State Mechanism 
A final concentration of 0.4 μM PA1225 turnover with 0.2 mM NADPH and 25 to 200 μM 
benzoquinone was monitored in the presence and absence of 0.150 mM NADP+ in 150 mM NaCl, 
pH 6.0, at 25oC using a spectrophotometer. NADPH was dissolved in enzymatic buffer to prepare 
a 10 mM stock and subsequently diluted to a final concentration of 0.2 mM in the enzymatic 
reaction. Benzoquinone was prepared by dilution of a 25 mM benzoquinone stock to achieve 25 
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to 200 μM benzoquinone. NADPH was added to the reaction mixture last to initiate data 
acquisition. The initial rates were normalized to account for the non-enzymatic reaction between 
NADPH and benzoquinone. Each measurement was done in triplicate. 
 
2.9 Flavin-monitored Turnover 
The turnover of PA1225 with NADPH and O2 was monitored between 300 to 700 nm using 
a stopped-flow spectrophotometer equipped with photodiode array in 20 mM sodium phosphate, 
150 mM NaCl, 10% glycerol, pH 6.0, at 25 oC. The instrument was set up to acquire 500 scans 
every 750 ms for a total acquisition time of 2.5 min. PA1225 was prepared by passing through a 
PD 10 column equilibrated in 20 mM sodium phosphate, 150 mM NaCl, 10% glycerol, pH 6.0, to 
a final volume of 3 mL. The enzyme was rapidly mixed with equal amounts of buffer, and a single 
scan of the enzyme was used to calculate the concentration of enzyme (14 μM). The concentrations 
of NADPH and molecular oxygen after rapid mixing with the enzyme were 25 μM and 253 μM, 
respectively, and the spectra were analyzed using Kinetic Studio software suite (Hi-Tech 
Scientific, Bradford on Avon, U.K.). 
 
2.10 Data Analysis 
Kinetic data were fit using KalediaGraph (Synergy Software, Reading, PA) and Kinetic 
Studio software suite Enzfitter (Hi-Tech Scientific, Bradford on Avon, U.K.). The steady-state 
kinetic parameters at varying concentrations of NADPH and fixed concentration of quinone were 
determined by using the Michaelis-Menten equation for a single substrate. 
Stopped-flow traces of time-resolved flavin reduction were fit to Eq. 1, which describes a 
single-exponential process for flavin reduction where kobs represents the observed first-order rate 
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constant for the reduction of enzyme-bound flavin at any given concentration of the substrate 
associated with the absorption changes at 460 nm, A represents the absorbance at 460 nm at any 
given time, B is the amplitude of the decrease in absorbance, t is the time, and C is the offset value 
at infinite time that accounts for the non-zero absorbance of the fully reduced enzyme bound flavin.  
A = B exp (kobst) + C        (1) 
Concentration dependence of the observed rate constants for flavin reduction was analyzed 
with Eq. 2 or Eq. 3 which describe hyperbolic trends without and with a y-intercept, where kobs 
represents the observed first-order rate constant for the reduction of the enzyme-bound flavin at 
any given substrate concentration (S), kred is the limiting first-order rate constant for flavin 
reduction at saturating substrate concentrations, krev is the limiting first-order rate constant for the 
reverse of flavin reduction, and Kd is the apparent equilibrium constant for the dissociation for the 
enzyme-substrate complex into free substrate and enzyme.  
kobs= 
kred S
Kd + S
            (2) 
kobs= 
kred S
Kd + S
+ krev          (3) 
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3 RESULTS 
3.1 Overexpression and Purification 
Initially, the pa1225 gene was cloned from the genomic DNA of Pseudomonas aeruginosa 
PAO1, and the gene product PA1225 was purified using DEAE anion-exchange chromatography. 
During purification, the protein-bound cofactor was progressively released from the protein during 
exposure to high salt concentrations with ammonium sulfate precipitation and elution of the 
column with 1 M NaCl (data not shown). SDS-PAGE analysis of the partially purified enzyme 
further revealed several protein bands on the gel, indicating that the enzyme preparation would 
require further purification steps needed to isolate PA1225 to levels suitable for biochemical 
studies. For these reasons, an alternate strategy to produce and isolate the protein was considered. 
To minimize the loss of cofactor due to high salt concentrations during purification, the 
pa1225 gene was sub-cloned from plasmid pET20b(+)/pa1225 to incorporate a C-terminal His-
tag. The recombinant PA1225 protein with an engineered histidine tag was overexpressed in 
Escherichia coli strain Rosetta(DE3)pLysS, and the gene product was purified to satisfactory 
yields by HiTrapTM chelating HP 5 mL affinity column as described in the experimental 
procedures. The specific activity of the enzyme increased from 1.0 U/mg measured in the cell-free 
extract to 3.0 U/mg after purification. As shown in Figure 1, the enzyme purification process 
demonstrated a satisfactory degree of PA1225 purity. The purified enzyme was found to be stable 
and active for several months when stored in 20 mM Tris-Cl, 150 mM NaCl, 10% (v/v) glycerol, 
pH 8.0, at -20 oC. 
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Figure 1: SDS-Page of PA1225. Protein purification of PA1225 visualized on a 12% 
polyacrylamide gel. Lane a: protein markers. Lane b: total cell-free extract. Lane c: flow-through 
during protein loading onto a nickel-NTA column. Lane d: protein elution with 50 mM imidazole. 
Lane e: PA1225 after elution with 200 mM imidazole. Lane f: PA1225 after dialysis against 20 
mM Tris-Cl, 150 mM NaCl, 10% glycerol (v/v), pH 8.0, and centrifugation at 12,000 x g.    
 
 
3.2 Cofactor Identification 
PA1225 is annotated in the Pfam consortium database14 as an NAD(P)H-dehydrogenase 
with a flavodoxin-like fold, suggesting the presence of either FMN or FAD as a cofactor. 
Consistent with the enzyme being a flavoprotein, the UV-visible absorption spectrum of PA1225 
exhibited maxima at 380 nm and 460 nm at pH 6.0 (Figure 2A). The identity of the cofactor was 
established with fluorescence emission spectroscopy and MALDI-TOF spectrometry. The enzyme 
was heat-denatured by boiling at 100 oC for 20 min, and the flavin was isolated after removal of 
the denatured protein by centrifugation at 12,000 x g. The extracted cofactor emitted light at 525 
nm upon excitation at 460 nm (Figure 2A inset, solid line). Upon addition of 1 U 
phosphodiesterase, the fluorescence emission of the extracted flavin increased 4-fold (Figure  2A 
inset, dashed line), ruling out FMN as being the cofactor.15 FAD, with a molecular formula of 
C27H33N9O15P2, has a monoisotopic mass of 785.1 g/mol; as shown in Figure 2B, a negative ion 
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mode MALDI-TOF spectrometric analysis of the flavin extracted from PA1225 showed a major 
peak at 784.1 m/z, consistent with deprotonated FAD, thus confirming FAD as the cofactor of the 
enzyme. The extinction coefficient (Ԑ460nm) of the enzyme-bound FAD was calculated to be 10,100 
M-1 cm-1 from the extinction coefficient of FAD in solution after boiling the enzyme to extract the 
flavin and removing the denatured protein by centrifugation at 12,000 x g. 
 
 
Figure 2: UV-visible absorption spectrum, fluorescence emission, and MALDI-TOF(-) spectra of 
PA1225. (A) UV-visible absorption spectrum of oxidized PA1225 in 20 mM Tris-Cl, 150 mM 
NaCl, 10% glycerol (v/v), pH 6.0. Inset: fluorescence emission spectrum before (solid line) and 
after (dashed line) treatment with phosphodiesterase I. (B) MALDI-TOF(-) of the extracted 
PA1225 flavin reveals well-resolved peaks at 784.1, 785.1 and 786.1 m/z. 
 
 
 
3.3 Reducing Substrate Identification 
NADPH was chosen as a potential reducing substrate based on an amino acid sequence 
alignment of PA1225 to NQO1 (i.e., 21%), suggesting that the enzyme may oxidize NADPH or 
NADH. Enzyme turnover of PA1225, at a final concentration of 0.4 µM, was monitored with a 
fixed, saturating concentration of 0.2 mM benzoquinone and NADPH between 25 and 200 µM at 
pH 6.0 and 25 oC to determine the apparent steady-state kinetic parameters at varying 
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concentration of the reducing substrate NADPH. The concentration dependence of NADPH on the 
initial rate of enzyme reaction displayed a hyperbolic behavior when fit to the Michaelis-Menten 
equation(Figure 3A), allowing for the determination of the first-order rate constant for enzyme 
turnover at saturating NADPH concentrations and a fixed concentration of benzoquinone(appkcat), 
the Michaelis constant for NADPH (appKm), and the second-order rate constant for the capture of 
NADPH into enzyme-substrate complexes that proceed to catalysis (app(kcat/Km)). The apparent 
steady-state kinetic parameters determined here are summarized in Table 2.  
The catalytic parameters for PA1225 were also obtained with NADH as the reducing 
substrate for PA1225 at a fixed concentration of 0.2 mM benzoquinone to elucidate whether the 
enzyme has a preference for NADPH or NADH as a reducing substrate. With NADH at pH 6.0, it 
was not possible to saturate the enzyme and obtain appkcat and 
appKm values, as shown in Figure 3B. 
However, an accurate app(kcat/Km) value could be determined from the slope of the initial rate of 
reaction as a function of the concentration of NADH (Table 2). 
 
 
Table 2: Apparent steady-state kinetic parameters of PA1225 at a fixed concentration of 
benzoquinone and varying concentrations of NADH or NADPH at pH 6.0. 
NADPH or NADH appkcat, s-1 appKm, μM kcat/Km, M-1 s-1 
NADPH 10.1 ± 0.3 82 ± 5 124,000 ± 5,000 
NADH NDa NDa 3,000 ± 100 
The experiment was done in duplicate in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, at 25 
oC, with a fixed concentration of 0.2 mM benzoquinone and NADH ranging from 50 to 200 μM 
or NADPH ranging from 25 to 200 μM. aSaturation could not be achieved with NADH.  
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Figure 3: Concentration dependence of the initial rate of reaction of PA1225 with NADPH (A) 
and NADH (B). Measurements were conducted with 0.2 mM benzoquinone in 20 mM Tris-Cl, 
150 mM NaCl, pH 6.0, 25oC, in duplicate, with the average values being displayed. 
 
 
 
3.4 Oxidizing Substrate Identification 
Quinones were selected as potential oxidizing agents based on the high amino acid 
sequence identity of PA1225 with NQO2 and NQO1 (i.e., 30% and 21%), which can reduce 
quinones effectively.  In addition, the KEGG pathway (pae00130) suggests PA1225 to be involved 
in quinone metabolism in P. aeruginosa PAO1. Initial rates of enzyme reaction were obtained with 
a fixed concentration of 0.2 mM NADPH and 0.4 μM PA1225 with benzoquinone, coenzyme Qo, 
tetramethyl benzoquinone, 2,6-dimethoxy-benzoquinone, or 1,4-naphthoquinone in the range 
between 25 and 200 μM (Table 3). With tetramethyl benzoquinone, 2,6-dimethoxy-benzoquinone, 
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and 1,4-naphthoquinone, substrate inhibition was observed at concentrations >100 μM (data not 
shown). With all quinones tested, other than the appkcat values the apparent steady-state kinetic 
parameters could not be determined because the enzyme was saturated with quinone 
concentrations as low as 25 µM, which was the lowest limit that could be used to obtain sensible 
kinetic traces. These data are consistent with Km values for the quinone oxidizing substrates being 
≤1 μM, which is 20-fold lower than the lowest concentration of quinone that could be tested 
experimentally. 
 
Table 3: Apparent kcat values of PA1225 with various oxidizing substrates. 
Oxidizing Substrates appkcat, s-1 
1,4-benzoquinonea 5.9 ± 0.1 
2,6-dimethoxy-1,4-benzoquinonea 5.5 ± 0.3 
tetramethyl benzoquinonea 5.5 ± 0.2 
coenzyme Qo
a 4.5 ± 0.8 
1,4-naphthoquinonea 3.3 ± 0.8 
atmospheric oxygenb 0.4 ± 0.2 
methyl redc  0 
aAverage value for the initial rate of reaction determined with concentrations of quinone between 
25 µM and 100 µM and a fixed concentration of 0.2 mM NADPH. bAtmospheric oxygen 
concentration tested at 25 oC. cMethyl red was 0.2 mM. All measurements were carried out in 
triplicate in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, at 25 oC.  
 
 
Molecular oxygen was chosen as a potential oxidizing substrate for PA1225 because its 
FAD cofactor is known to reduce oxygen in solution and when bound to oxidases and 
monooxygenases.16 The enzymatic activity of PA1225 with molecular oxygen was investigated by 
measuring the consumption of 0.2 mM NADPH with 0.4 μM PA1225 in 20 mM sodium phosphate, 
150 mM NaCl, pH 6.0, at 25 oC, using a spectrophotometer equipped with a water bath. PA1225 
displayed an NADPH oxidase activity of 0.4 ± 0.1 s-1 with atmospheric oxygen concentrations at 
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25 oC (Table 3). Thus, the enzyme has a negligible activity with molecular oxygen as the oxidizing 
substrate, suggesting that PA1225 is not an oxidase or a monooxygenase. 
PA1225 was previously proposed by others to have azoreductase activity.17  To test this 
hypothesis, methyl red was used as an oxidizing substrate at a concentration of 0.2 mM. The initial 
rate of enzyme reaction was followed at 340 nm with a fixed concentration of 0.2 mM NADPH 
and 0.4 μM PA1225 in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, at 25 oC, using a 
spectrophotometer. No significant enzymatic reduction of methyl red was observed over 1 min, 
indicating that PA1225 is not an azoreductase. 
 
 
 
3.5 Steady-state Kinetic Mechanism with NADP+ 
To further understand the mechanistic characterization of PA1225, the steady-state kinetic 
mechanism was determined for the enzyme. The apparent steady-state kinetics with 0.4 μM 
PA1225 and 0.2 mM NADPH in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, at 25 oC 
showed the same initial rate was obtained between 25 to 200 μM of benzoquinone (Table 4). 
Therefore, the steady-state kinetic mechanism of PA1225 could not be determined by varying both 
NADPH and benzoquinone. Consequently, inhibition patterns were investigated with NADP+ as a 
substrate during PA1225 turnover with saturating NADPH and benzoquinone to establish the 
steady-state mechanism of PA1225. Due to benzoquinone saturating, the reduced form of the 
enzyme (Ered in scheme 1) in the enzyme-substituted mechanism is always in complex with 
benzoquinone. Therefore, no inhibition should be observed, consistent with Ping-Pong Bi-Bi 
steady-state kinetic mechanism.  In agreement with this hypothesis (Figure 5), no inhibition was 
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observed with addition of 150 µM NADP+ to the reaction mixture compared with zero NADP+ 
with varying benzoquinone concentrations of 25 µM to 200 µM (Table 4). 
 
 
Figure 4: Steady-state kinetics of PA1225 follows Ping-Pong Bi Bi mechanism. 
 
 
Table 4: Substrate inhibition pattern with NADP+ 
[benzoquinone], μM 
appkcat, s-1 
0 μM NADP+ 150 μM NADP+ 
25 5.8 ± 0.2 6.1 ± 0.4 
50 5.6  0.2 5.8  0.4 
100 5.9 ± 0.2 6.0 ± 0.3 
150 6.2 ± 0.4 6.3 ± 0.4 
200 5.9 ± 0.3 5.7 ± 0.2 
PA1225 catalytic rate with 0 or 150 μM of NADP+ with 0.2 mM NADPH and varying 1,4-
benzoquinone concentrations in 20 mM sodium phosphate, 150 mM NaCl, pH 6.0, at 25oC. 
 
 
 
3.6 Reductive Half-reaction at pH 6.0 
To gain information on the hydride transfer reaction from the NADPH to the enzyme-
bound flavin, the reduction of the FAD cofactor was followed by monitoring the decrease in 
absorbance at 460 nm at pH 6.0 and 25 oC in a stopped-flow spectrophotometer. The experiment 
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was carried out aerobically because of the negligible activity of PA1225 with oxygen as an 
oxidizing substrate (see above). PA1225, at a final concentration of 10 µM, was fully reduced by 
NADPH in a monophasic pattern (Figure 5A-B); the stopped-flow traces were fit with Eq. 1 to 
extract the observed rate constants for flavin reduction (kobs) at different concentrations of 
NADPH. The kobs value increased hyperbolically with increasing NADPH concentration (Figure 
5C), defining a limiting rate constant for flavin reduction (kred) at saturating concentrations of 
NADPH and a dissociation constant defining equilibria between free enzyme and NADH and 
enzyme-NADH complex that proceed to catalysis (Kd). A fit of the data with Eq. 3 returned a value 
of zero for the y-intercept, consistent with a negligible rate constant for the reverse flavin reduction 
and justifying fitting the data with Eq. 2 (Table 5). 
 The rate constant of flavin reduction was also investigated with NADH as a reducing 
substrate. As for the case of NADPH, the stopped-flow traces were monophasic at all the 
concentrations of NADH used and resulted in the full reduction of the enzyme-bound flavin to the 
hydroquinone state (Figure 6A-B). The rate constant for flavin reduction kobs increased 
hyperbolically with increasing NADH concentration, but the best fit of the data was obtained with 
Eq. 3, indicating a significant value for the reverse flavin reduction (krev) (Figure 6C). The kinetic 
parameters associated with the reductive half reaction of PA1225 with NADH are summarized in 
Table 5. 
 
 
3.7 Effect of pH on the Reductive Half-reaction  
The effect of pH on the reductive half-reaction with either NADH or NADPH was 
investigated in a stopped-flow spectrophotometer at pH 8.0, 9.0, and 10.0 to gain insights into 
ionizations processes associated with substrate binding and flavin reduction. In all cases, the 
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stopped-flow traces were monophasic, yielded fully reduced enzyme, and demonstrated hyperbolic 
concentration dependence of the kobs value yielding negligible krev values (data not shown). As 
illustrated in Table 5, the kred value was independent of pH with both NADPH and NADH, with 
an average value of ~10 s-1 for NADPH and ~5 s-1 with NADH. Irrespective of the reducing 
substrate the Kd had similar values at pH ≥9.0, with NADPH showing a ~7-fold smaller Kd value 
than NADH (Table 5).  At pH 6.0, however, the Kd was an order of magnitude smaller than at high 
pH with both reducing substrates (Table 5). The reductive half-reaction could not be studied at pH 
7.0 due to enzyme instability, probably associated with the computed pI value of 6.9 for PA1225. 
 
 
Table 5: Reductive half-reaction kinetic parameters at pH 6.0, 8.0, 9.0, and 10.0. 
pH kred, s-1 krev, s-1 Kd, mM R2 
NADPH 
6.0a 10.4 ± 0.1 0d 0.070  0.002 0.993 
8.0b 11.2  0.1 0d 2.5  0.1 0.998 
9.0b 9.3 ± 0.4 0d 1.7 ± 0.1 0.999 
10.0c 9.9 ± 0.3 0d 1.7 ± 0.1 0.997 
NADH 
6.0a 4.7 ± 0.2 1.6 ± 0.3 1.8 ± 0.5 0.998 
8.0b 4.1 ± 0.1 0d 7.7 ± 0.5 0.999 
9.0b 4.9 ± 0.3 0d 12.0 ± 1.0 0.998 
10.0c 5.7 ± 0.2  0d 12.0 ± 0.6 0.999 
Experiment was carried out in a20 mM sodium phosphate, or b20 mM Tris-Cl, or c20 mM 
sodium pyrophosphate in the presence of 150 mM NaCl, 10% glycerol, at 25 oC with 10 μM 
PA1225. dA krev value
 not significantly different from 0 was obtained from fitting the data to Eq. 
3. 
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Figure 5: Reductive half-reaction of PA1225 with NADPH at pH 6.0. (A) Stopped-flow traces of 
PA1225 at 460 nm with increasing NADPH concentrations, log time scale fit, and fit of the data 
to Eq 1. For clarity, one experimental point out of every five is shown (vertical lines). Instrument 
dead time is 2.2 ms (B) Time-resolved absorbance spectroscopy of PA1225 before (dark line) and 
after mixing (light line) with 1 mM NADPH. (C) Concentration dependence of the observed rate 
constant (kobs) for flavin reduction with fit of the data to Eq 2; each data point was done in triplicate. 
All experiments were carried out in 20 mM sodium phosphate, 150 mM NaCl, 10% glycerol, pH 
6.0, at 25 oC. 
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Figure 6: Reductive half-reaction of PA1225 with NADH at pH 6.0. (A) Stopped-flow traces of 
PA1225 at 460 nm with increasing NADH concentrations, log time scale fit, and fit of the data to 
Eq 1. For clarity, one experimental point out of every five is shown (vertical lines). Instrument 
dead time is 2.2 ms (B) Time-resolved absorbance spectroscopy of PA1225 before (dark line) and 
after mixing (light line) with 1 mM NADH. (C) Concentration dependence of the observed rate 
constant (kobs) for flavin reduction with fit of the data to Eq 2; each data point was done in triplicate. 
All experiments were carried out in 20 mM sodium phosphate, 150 mM NaCl, 10% glycerol, pH 
6.0, at 25 oC. 
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3.8 Flavin-monitored Turnover  
To establish whether transient species were formed during turnover of the enzyme, the 
oxidation state of the enzyme-bound flavin was monitored between 300 nm and 700 nm upon 
mixing PA1225 with 25 μM NADPH and 253 μM oxygen in a stopped-flow spectrophotometer 
equipped with photodiode array at pH 6.0 and 25 oC. As shown in Figure 7, 14 μM PA1225 was 
fully reduced with NADPH in 3 s, as denoted by the decrease in absorbance at 460 nm (Figure 
7). The fully reduced enzyme was then slowly oxidized by molecular oxygen, as indicated by the 
increase in absorbance at 460 nm observed between 10 s and 100 s. The initial full reduction of 
the enzyme by NADPH and the subsequent slow oxidation by molecular oxygen agree well with 
a fast reduction of the enzyme-bound flavin as determined in the reductive half-reaction and the 
almost negligible oxidase activity of the enzyme (see above). The increase in absorbance at 380 
nm, which paralleled the increase in absorbance at 460 nm (Figure 7), is consistent with a direct 
conversion of the reduced flavin to the oxidized state without transient accumulation of flavin-
derived species, such as C4a-peroxy- or C4a-hydroperoxy-flavin.  
 
Figure 7: Flavin-monitored turnover of the enzyme-bound flavin in PA1225 during turnover with 
atmospheric oxygen and 25 μM NADPH. The experiment was carried out in 20 mM sodium 
phosphate, 150 mM NaCl, 10% glycerol, pH 6.0, at 25 oC. 
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4 DISCUSSION 
PA1225 displayed a marked preference for NADPH as the reducing substrate made 
apparent by comparing the kcat/Km and Kd values with respect to NADH at pH 6.0. Evidence 
supporting this statement comes from a 40-fold difference in the kcat/Km value observed during 
PA1225 turnover with saturating benzoquinone, where the second-order rate constant for NADPH 
kcat/Km was 124,000 ± 5,000 M
-1 s-1 and that for NADH was 3,100 ± 100 M-1 s-1. Additionally, 
substrate binding is ~25-fold tighter for NADPH than NADH as determined by comparing the Kd 
values with the reducing substrates determined at pH 6.0 for PA1225 during the reductive half-
reaction (Table 2).  
PA1225 catalyzes the reduction of various quinones as shown in Table 3, yet has a clear 
preference for benzoquinone and quinones with small rings over molecular oxygen at pH 6.0. The 
enzyme is not active with methyl red as an oxidizing substrate, consistent with PA1225 not being 
an azoreductase. Evidence to support this conclusion comes from the appkcat values, or lack thereof, 
obtained during PA1225 turnover with benzoquinone, 2,6-dimethoxy-1,4-benzoquinone, 
tetramethyl benzoquinone, coenzyme Qo, 1,4-naphthoquinone, methyl red, or molecular oxygen 
as oxidizing substrates with fixed, saturating NADPH concentration at pH 6.0 (Table 3). Accurate 
values of appKm and kcat/Km for all oxidizing substrates could not be measured due to (1) quinones 
saturating the enzyme at all concentrations used in this study, (2) substrate inhibition was observed 
with increased substituent groups to the quinone nucleus, (3) the kcat values dependence on O2 
concentration dependence could not be achieved due to PA1225 poor oxidase activity at 25 oC, 
and (4) PA1225 does not display azoreductase activity with methyl red as substrate. It is therefore 
estimated that the appKm for benzoquinone(s) is at least 20-fold below that of 25 μM, as this was 
the lowest saturating concentration of quinone used during PA1225 turnover. Furthermore, 
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increased substituents on the quinone nucleus decreased the apparent catalytic rate during PA1225 
turnover. This type of behavior was observed previously with NQO1, where kinetic data with one-
, two-, and three-ring quinones showed that increased ring size decreased maximal velocity and 
decreased binding affinity.18, 19 In addition to quinones and O2 as oxidizing substrates, PA1225 
was postulated by others to display azoreductase activity.17 However, PA1225 does not display 
azoreductase activity at pH 6.0 with saturating NADPH. Enzymes with flavodoxin-like fold 
purified from P. aeruginosa PAO1 such as paAzoR1, paAzoR2, and paAzoR3 cleave azo bonds 
and reduce quinones by coupling the reaction with NADH or NADPH.19 Amino acid sequence 
comparison of PA1225 to paAzoR1, paAzoR2, and paAzoR3 shows that PA1225 has a sequence 
identity <23%, consistent with the observation that the enzyme is not able to act as an azoreductase.  
Stopped-flow data demonstrate PA1225 oxidation with O2 does not facilitate the formation 
of C4a-peroxy(FADOO-) or -hydroperoxy(FADOOH) flavin-derived species. Evidence to support 
this conclusion comes from the lack of spectrophotometric detection of these flavin-derived 
species during flavin-monitored turnover with NADPH and molecular oxygen at 25 oC (Figure 7). 
If a C4a-peroxy or -hydroperoxy ﬂavin were an obligatory intermediate during the oxidation of 
the hydroquinone in PA1225, it would transiently accumulate during the oxidation of the reduced 
ﬂavin, allowing for its spectrophotometric detection at 380 nm. Alternatively, one would have to 
assume a short-lived transient species due to its rate of decay being much faster than its rate of 
formation. Based on the results presented and the lack of evidence for flavin-derived adducts with 
oxygen species, a mechanism in which PA1225 facilitates the formation of FADOO- or FADOOH, 
which would classify the enzyme as a monooxygenase, is ruled out. In contrast to PA1225, 
formation of FADOOH  mediated by NADP
+ in N-hydroxylating flavin monooxygenase was 
observed.20 
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PA1225 follows a Ping-Pong Bi-Bi mechanism. Evidence to support this conclusion comes 
from the lack of product inhibition with 0.150 mM NADP+, in the presence of saturating NADPH 
and benzoquinone, which rules out the potential of a random mechanism in which uncompetitive 
inhibition patterns would be observed. Stopped-flow data demonstrates the reducing substrate 
must bind and react first to reduce FAD in the absence of oxidizing substrate. Therefore, PA1225 
cannot possibly follow a random sequential mechanism. Taking these results in consideration 
establishes a Ping-Pong Bi-Bi mechanism for PA1225.  
PA1225 binds the reducing substrate NADPH or NADH tighter at pH 6.0 compared to pH 
≥9.0. Evidence for this conclusion comes from the effect of pH on the kinetic parameter defining 
substrate binding, Kd, values between pH 6.0 and pH 10.0 for both NADPH or NADH, as shown 
in Table 5. At pH 6.0 with NADPH as the reducing substrate, the Kd value was 0.070 mM as 
compared to 1.7 mM observed at pH 9.0 and pH 10.0, accounting for a 25-fold difference in 
substrate binding. A similar behavior was observed at pH 6.0 with NADH as the reducing 
substrate, for which the Kd value was 1.8 mM as compared to 12.0 mM observed at pH 9.0 and pH 
10.0, which accounts for 7-fold difference in substrate binding. With the available data, and in 
the absence of structural data that could inform on the interactions of the enzyme with NAPDH 
and NADH it is not possible to provide a rationale to explain these differences between the Kd 
value with NADPH and NADH. 
Hydride transfer is fully rate-limiting for the overall turnover of PA1225 with NADPH and 
benzoquinone at low pH. This conclusion is supported by the similar rate constants of 10 s-1 
observed during the reductive half-reaction with NADPH and the catalytic rate constant 
accounting for the full turnover of PA1225 with saturating NADPH and benzoquinone at pH 6.0. 
The observed rate of flavin reduction at pH 6.0 with saturating concentrations of NADPH (kred) 
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was 10.4 s-1, and the apparent steady-state turnover constant at saturating NADPH and quinone at 
pH 6.0 was 10.1 s-1. These data establish hydride transfer (k3 in Figure 4) as the rate limiting step 
in PA1225 turnover at low pH values.  
Hydride transfer from NAD(P)H to FAD is independent of any ionizable group with a pKa 
value between pH 6.0 and 10.0. Evidence to support this conclusion comes from the effect of pH 
on the stopped-flow kinetic data between pH 6.0 and 10.0 for both NADH or NADPH, 
demonstrating that the kred values do not change as a function of the pH value (Table 5). This pH-
independent hydride transfer is likely explained by - stacking of the nicotinamide ring to the 
isoalloxazine ring of the flavin, providing stability and orientation for hydride transfer to occur in 
the absence of ionizable group(s). This type of interaction was previously observed with NQO1; 
in that case, the aromatic ring of NADP+ stacks 3.4 Å apart onto the flavin and shares the same 
binding site with quinones.18, 21 Truncation of the N-terminal domain in NQO2 removes residues 
that would otherwise be involved in binding the ADP moiety of NADPH; however, stacking of 
nicotinamide derivatives can still occur through - stacking. 22, 23 The lack of pH effects on the 
hydride transfer reaction also implies that no ionizable groups in the active site of the enzyme 
interact with the nicotinamide portion of the reducing substrate, since if this were the case one 
would expect the presence or absence of a charge to affect the rate constant for the hydride transfer 
reaction. 
Ionizable group(s) on the enzyme are nonetheless involved in NAD(P)H binding. Evidence 
to support this conclusion comes from increasing Kd values with increasing pH with either NADH 
or NADPH as the reducing substrate (Table 3). In the absence of structural information on the 
enzyme, it is not possible to propose an identity for the protonated group(s) responsible for the 
tighter binding of the reducing substrate at low pH. 
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The physiological role of PA1225 has not been investigated yet, but the available evidence 
allows one to speculate that the enzyme may work in tandem with other enzymes in P. aeruginosa 
PAO1 for the detoxification of quinones to hydroquinones to prevent the formation of highly 
reactive semiquinone radicals.24 An additional role for PA1225 could be as a redox sensor by 
reducing the cellular quinone pool which, consequently, would lead to shifting metabolism from 
respiratory to fermentative.18 This hypothesis is in line with current evidence on PA1225 
suggesting a role in redox sensing. First, PA1225 is overexpressed with nitronate monooxygenase 
(NMO) as shown in knockout studies of a LysR regulator in P. aeruginosa PAO1.8 Second, NMO 
physiological substrate P3N is known to irreversibly inhibit succinate dehydrogenase.9 
Consequently, inhibition of succinate dehydrogenase would result in accumulation of succinate. 
Indeed, succinate accumulation was observed in knock out studies of the succinate dehydrogenase 
complex in Staphylococcus aureus, which resulted in accumulation of succinate and acetic acid.25 
This accumulation of metabolites thus lowered the pH of the cell as a result of overactive urease 
activity.25 
In summary, based on the results presented in this study PA1225 is an FAD-dependent 
NADPH:quinone reductase. Both fluorescence emission and MALDI-TOF establish FAD as the 
cofactor of the enzyme. The preference for quinones and NADPH over NADH is demonstrated by 
the biochemical characterization of the enzyme using a combination of steady-state and rapid 
kinetics with NADH or NADPH and various oxidizing substrates. PA1225 has a clear preference 
for NADPH as the reducing substrate as determined by a 40-fold difference in kcat/Km for NADPH 
over NADH at pH 6.0. The pH effect on the rate of flavin reduction with NADH or NADPH as 
substrates shows the independence of pH on the reduction of the enzyme-bound FAD. 
Additionally, pH effects on the binding of NADH or NADPH showed better binding at low pH, 
32 
with no effect on the chemistry controlling hydride transfer. Further investigation involving knock-
out studies of pa1225 gene and the determination of the crystal structure of this enzyme will need 
to be carried out to further understand the role of this enzyme in P. aeruginosa PAO1.  
33 
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